2015
DOI: 10.1016/s2055-6640(20)30510-0
|View full text |Cite
|
Sign up to set email alerts
|

The EPIICAL project: an emerging global collaboration to investigate immunotherapeutic strategies in HIV-infected children

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
31
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 24 publications
(31 citation statements)
references
References 45 publications
0
31
0
Order By: Relevance
“…The objective of the current study was to generate a T cell immune signature using a computational approach to evaluate the relationships between immune activation, immune checkpoint markers, HIV-specific T cell responses and viral reservoir measurements in a cohort of long-term ART suppressed perinatally HIV-infected adolescent participants that initiated ART within 2 years of life [ 31 32 ]. We identified a 9-marker immune signature that was able to discriminate between perinatally infected young individuals with high and low HIV viral burden.…”
Section: Introductionmentioning
confidence: 99%
“…The objective of the current study was to generate a T cell immune signature using a computational approach to evaluate the relationships between immune activation, immune checkpoint markers, HIV-specific T cell responses and viral reservoir measurements in a cohort of long-term ART suppressed perinatally HIV-infected adolescent participants that initiated ART within 2 years of life [ 31 32 ]. We identified a 9-marker immune signature that was able to discriminate between perinatally infected young individuals with high and low HIV viral burden.…”
Section: Introductionmentioning
confidence: 99%
“…Children starting ART within 3 months of birth remain frequently HIV-1 seronegative after losing maternal antibodies and lack HIV-specific cellular immune responses, making them potentially more susceptible to uncontrolled viral replication when ART is interrupted [ 8 , 9 ]. Identifying factors and biomarkers, such as seronegativity, associated with limited viral reservoir size will potentially aid identification of participants for future proof-of-concept studies aimed at inducing ART-free viral remission [ 10 ].…”
mentioning
confidence: 99%
“…The CARMA study (Child and Adolescent Reservoir Measurements on Early Suppressive ART) is part of the existing EPIICAL consortium (Early Treated Perinatally HIV Infected Individuals: Improving Children’s Actual Life; www.epiical.org ), an international collaboration whose aim is to select promising HIV-1 therapeutic strategies and to identify candidates among perinatally HIV-1–infected children and adolescents and is described in detail previously [ 10 ].…”
mentioning
confidence: 99%
“…Forty PHIV, who started ART within the first two years of life, were recruited cross -sectionally in CARMA (Child and Adolescent Reservoir Measurements on early suppressive ART). This protocol is part of the existing EPIICAL consortium (Early treated Perinatally HIV-Infected individuals: Improving Children's Actual Life) [25]. Inclusion criteria were as follows: (1) ≥5 years of age, (2) viral suppression (<400 copies/mL) achieved in the first year of ART and maintained for at least five years, and (3) plasma viral load of <50 HIV-1 RNA copies/ mL at enrolment.…”
Section: Study Participantsmentioning
confidence: 99%